↓ Skip to main content

Dove Medical Press

Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, February 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
15 Mendeley
Title
Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone
Published in
International Journal of Chronic Obstructive Pulmonary Disease, February 2022
DOI 10.2147/copd.s342357
Pubmed ID
Authors

David B Price, William Henley, José Eduardo Delfini Cançado, Leonardo M Fabbri, Huib A M Kerstjens, Alberto Papi, Nicolas Roche, Elif Şen, Dave Singh, Claus F Vogelmeier, Sara Barille, Elena Nudo, Victoria Carter, Derek Skinner, Rebecca Vella, George Georges

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 13%
Other 1 7%
Student > Doctoral Student 1 7%
Lecturer 1 7%
Student > Master 1 7%
Other 1 7%
Unknown 8 53%
Readers by discipline Count As %
Medicine and Dentistry 5 33%
Social Sciences 1 7%
Unknown 9 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2022.
All research outputs
#17,301,727
of 25,392,582 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#1,733
of 2,578 outputs
Outputs of similar age
#307,574
of 517,864 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#24
of 41 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,578 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 517,864 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.